Thyroid cancer trials in United Kingdom

In United Kingdom 9 Also abroad 226

9 trials · From ClinicalTrials.gov, checked 11 November 2026. Ask the study team whether a trial fits you.

Phase 1/2Taking people
Phase 1/2 Trial of S241656 in Selected RAS/MAPK Mutation- Positive Malignancies
Where
London, Manchester
Age
18 years and over
People
554 worldwide
Run by
Institut de Recherches Internationales Servier
See details and how to joinNCT05786924 · EU 2025-523474-16-00
Phase 2/3Taking people
DETERMINE Trial Treatment Arm 07: Dabrafenib in Combination With Trametinib in Adult, Paediatric and Teenage/Young Adult Patients With BRAF V600 Mutation-Positive Cancers.
Where
Belfast, Birmingham, Bristol, Cambridge, Cardiff, Edinburgh, Glasgow, Leicester, Liverpool, London, Manchester, Metropolitan Borough of Wirral, Newcastle, Oxford, Sheffield, Southampton, Sutton
Age
1 year and over
People
30
Run by
Cancer Research UK
See details and how to joinNCT07440290
Phase 2Taking people
A Study to Assess the Efficacy and Safety of FORE8394 in Participants With Cancer Harboring BRAF Alterations
Where
London, Manchester
Age
8 years and over
People
254 worldwide
Run by
Fore Biotherapeutics
See details and how to joinNCT05503797 · EU 2024-513578-23-00
Phase 1/2Taking people
A Study of Repotrectinib (TPX-0005) in Patients With Advanced Solid Tumors Harboring ALK, ROS1, or NTRK1-3 Rearrangements
Where
London, Manchester, Sutton
Age
12 years and over
People
500 worldwide
Run by
Turning Point Therapeutics, Inc.
See details and how to joinNCT03093116 · EU 2024-512606-25-00
No phaseTaking people
Hemithyroidectomy or Total-Thyroidectomy in 'Low-risk' Thyroid Cancers
Where
Bath, Birmingham, Bristol, Cambridge, Cardiff, Colchester, Crewe, Derby, Dundee, Edinburgh, Exeter, Falkirk, Gillingham, Glasgow, Ipswich, Leicester, Liverpool, London, Luton, Northampton, Norwich, Nottingham, Plymouth, Poole, Portsmouth, Rhyl, Sheffield, Taunton
Age
16 years and over
People
456
Run by
University College, London
See details and how to joinNCT05604963
Phase 2/3Taking people
DETERMINE Trial Treatment Arm 05: Vemurafenib in Combination With Cobimetinib in Adult Patients With BRAF Positive Cancers.
Where
Belfast, Birmingham, Bristol, Cambridge, Cardiff, Edinburgh, Glasgow, Leicester, London, Manchester, Metropolitan Borough of Wirral, Newcastle, Oxford, Sheffield, Southampton
Age
18 years and over
People
30
Run by
Cancer Research UK
See details and how to joinNCT05768178
Phase 2Taking people
APL-101 Study of Subjects With NSCLC With c-Met EXON 14 Skip Mutations and c-Met Dysregulation Advanced Solid Tumors
Where
London, Manchester, Surrey Quays
Age
18 years and over
People
497 worldwide
Run by
Apollomics Inc.
See details and how to joinNCT03175224 · EU 2024-514542-37-00
No phaseTaking people
To Perform a Post-market Study of the Performance of the Idylla ThyroidPrint Assay Using Clinical Samples in Predicting the Nature of Indeterminate Thyroid Nodules (ITNs) Across Multiple Centers.
Where
Truro
Age
18 years and over
People
100
Run by
Royal Cornwall Hospitals Trust
See details and how to joinNCT06849284
No phaseTaking people
Investigating Utility of ctDNA and Tumour Evolution in Advanced Thyroid Cancer
Where
London
Age
18 years and over
People
120
Run by
Royal Marsden NHS Foundation Trust
See details and how to joinNCT05837260